The latest New Drug Review covers Amgen’s migraine medication.
All News
Advertisement
What the experts have to say about recent shifts in pharmacy law and practice.
Advertisement
Our annual look at the best states to practice pharmacy, based on everything from salary to robbery statistics.
An unclear naming system for biosimilars could affect patient safety.
Advertisement
Small Doses is back, bringing you the pharmacy news you need in a way that works for you.
Advertisement
Turns out running a bar shares many similarities with running a pharmacy-but the mistakes cost a lot more.
How new technologies are enabling pharmacies to increase adherence and their bottom line.
The drug is the first approved under the agency's new, quicker generic approval designation.
Interested in cardiology? Here’s why you should consider becoming extra training and certification.
It’s time to fix the disconnect between what students are taught and what’s needed to practice.
If you’ve never thought about becoming certified, now is a great time to do it.
Our latest New Drug Review covers Dova’s most recent medication.
How pharmacies are stepping up confront an epidemic.
Walgreens announces Digital Marketing Platform
Pharmacogenomics helps pharmacists recognize how every patient requires a different approach.
NACDS supports the Patient Right to Know Drug Prices Act that ends gag clauses
How the disconnect between pharmacy schools and indepedent pharmacy ownership is being solved.
Advertisement
Advertisement
Trending on Drug Topics
1
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
2
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
3
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
4
Pharmacists as the Front Line of Vaccine Education and Access
5
